Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial)

Autor: Korjian, Serge, Braunwald, Eugene, Daaboul, Yazan, Mi, Michael, Bhatt, Deepak L., Verheugt, Freek W.A., Cohen, Marc, Bode, Christoph, Burton, Paul, Plotnikov, Alexei N., Gibson, C. Michael
Zdroj: In The American Journal of Cardiology 1 December 2018 122(11):1896-1901
Databáze: ScienceDirect
Externí odkaz: